1-1 of 1
on Behalf of the Latin American Cooperative Onco-Hematology Group (LACOHG)
Close
Sort by
Journal Articles

Subcutaneous Alemtuzumab in Patients with Refractory/Relapsed B-Cell CLL after a Fludarabine-Based Regimen. An Interim Analysis.

R. Fernando Bezares, German Stemmelin, Daniel Argentieri, Emilio Lanari, Efrain Guy-Garay, Reinaldo Campestri, Miguel Bartomioli, Juan Jose Garcia, Sergio Giralt, Gustav Milone, on Behalf of the Latin American Cooperative Onco-Hematology Group (LACOHG)
Journal: Blood
Blood (2006) 108 (11): 2843.
https://doi.org/10.1182/blood.V108.11.2843.2843
Published: 2006